TELA
HealthcareTELA Bio, Inc.
$1.10
$-0.04 (-3.51%)
Jan 5, 2026
Price History (1Y)
Analysis
TELA Bio, Inc. is a company in the healthcare sector and medical devices industry with a market capitalization of $50.32 million. It has 209 employees. As TELA Bio's financial metrics are not available, there is limited information to provide on its profitability, returns, or balance sheet. However, the lack of data for revenue (TTM), net income (TTM), EBITDA, free cash flow, cash, and debt indicates that these figures are not publicly disclosed. The company's valuation context includes a 52-week high of $3.10 and a 52-week low of $0.86, with a beta of 0.87. The absence of P/E ratio (TTM), forward P/E, price to book, price to sales, EV/EBITDA, dividend yield, payout ratio, revenue growth (YoY), earnings growth (YoY), return on equity, return on assets, debt to equity, and current ratio suggests that these metrics are not publicly available or applicable.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About TELA Bio, Inc.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Visit website →Key Statistics
- Market Cap
- $50.32M
- P/E Ratio
- N/A
- 52-Week High
- $3.10
- 52-Week Low
- $0.86
- Avg Volume
- 185.28K
- Beta
- 0.87
Company Info
- Industry
- Medical Devices
- Exchange
- NGM
- Country
- United States
- Employees
- 209